Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123164773 | 12316477 | 3 | F | 20160714 | 20160429 | 20160722 | EXP | CA-AMGEN-CANSP2016054049 | AMGEN | 0.00 | M | Y | 0.00000 | 20160722 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123164773 | 12316477 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 123164773 | 12316477 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 200 MG, QMO | 0 | 200 | MG | /month | |||||||
| 123164773 | 12316477 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | 0 | 20 | MG | TABLET | QD | ||||||
| 123164773 | 12316477 | 4 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 123164773 | 12316477 | 5 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 123164773 | 12316477 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 200 MG, QD | 0 | 200 | MG | TABLET | QD | ||||||
| 123164773 | 12316477 | 7 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 1000 MG, UNK | 0 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123164773 | 12316477 | 1 | Product used for unknown indication |
| 123164773 | 12316477 | 2 | Product used for unknown indication |
| 123164773 | 12316477 | 3 | Product used for unknown indication |
| 123164773 | 12316477 | 4 | Product used for unknown indication |
| 123164773 | 12316477 | 5 | Product used for unknown indication |
| 123164773 | 12316477 | 6 | Product used for unknown indication |
| 123164773 | 12316477 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123164773 | 12316477 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123164773 | 12316477 | Arthralgia | |
| 123164773 | 12316477 | Drug hypersensitivity | |
| 123164773 | 12316477 | Drug ineffective | |
| 123164773 | 12316477 | Knee arthroplasty | |
| 123164773 | 12316477 | Medical device implantation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |